| Financial Year |
March 31 2023 |
| Monetary Funds |
1,601,894,266.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
239,088,094.71 |
| Accounts Receivable |
2,070,970,312.52 |
| Advances to Suppliers |
25,889,429.04 |
| Other Receivables |
33,105,552.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
66,666.67 |
| Dividend Receivable |
-- |
| Inventories |
1,321,048,913.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,147,844,218.03 |
| Total Current Assets |
6,439,840,786.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
54,232,450.02 |
| Investment Properties |
49,089,170.68 |
| Fixed Assetes |
2,401,657,079.76 |
| Under-construction Projects |
236,414,021.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
265,281,173.74 |
| R&D expenses |
-- |
| Goodwill |
208,151,093.67 |
| Long-Term Deferred and Prepaid Expenses |
80,237,711.37 |
| Deferred Income Tax Assets |
43,322,175.82 |
| Other Non-Current Assets |
78,102,821.06 |
| Sub-Total of Non-Current Assets |
3,542,912,425.16 |
| Total Assets |
9,982,753,211.63 |
| Short-Term Loans |
1,882,097,590.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
924,816,886.58 |
| Accounts Payable |
1,585,050,386.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
88,603,783.17 |
| Taxes Payable |
29,528,007.09 |
| Interest Payable |
315,939.73 |
| Dividend Payable |
1,382,256.00 |
| Other payables |
69,079,801.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
4,616,294,495.65 |
| Long-term Loans |
54,141,581.07 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
121,043,091.91 |
| Total Liabilities |
4,737,337,587.56 |
| Paid-In Capital(Or Share Stock) |
793,656,894.00 |
| Capital Surplus |
2,759,328,774.73 |
| Surplus Reserve |
234,606,553.08 |
| LESS:Treasury Stock |
42,112,732.80 |
| Undistributed Profits |
1,492,278,180.26 |
| Minority Stockholder's Interest |
5,693,773.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,239,721,850.83 |
| Owner's Equity（Stockholder's Equity） |
5,245,415,624.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,982,753,211.63 |
